{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:12:51Z","timestamp":1771002771498,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,12,6]],"date-time":"2004-12-06T00:00:00Z","timestamp":1102291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,12,6]],"date-time":"2004-12-06T00:00:00Z","timestamp":1102291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2005,2,1]]},"DOI":"10.1038\/sj.bmt.1704786","type":"journal-article","created":{"date-parts":[[2004,12,6]],"date-time":"2004-12-06T10:08:28Z","timestamp":1102327708000},"page":"265-269","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Transplantation of allogeneic CD34-selected stem cells after fludarabine-based conditioning regimen for children with mucopolysaccharidosis 1H (M. Hurler)"],"prefix":"10.1038","volume":"35","author":[{"given":"L","family":"Grigull","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Beilken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Schrappe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Luecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Sander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Stanulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Rehe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Welte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"Lukacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Gal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K W","family":"Sykora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,12,6]]},"reference":[{"issue":"Suppl 2","key":"BF1704786_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1023\/A:1012463605992","volume":"24","author":"M Beck","year":"2001","unstructured":"Beck M . Variable clinical presentation in lysosomal storage disorders. J Inherit Metab Dis 2001; 24 (Suppl 2): 47\u201351.","journal-title":"J Inherit Metab Dis"},{"key":"BF1704786_CR2","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood.V87.11.4894.bloodjournal87114894","volume":"87","author":"C Peters","year":"1996","unstructured":"Peters C, Balthazor M, Shapiro EG et al. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 1996; 87: 4894\u20134902.","journal-title":"Blood"},{"key":"BF1704786_CR3","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood.V91.7.2601","volume":"91","author":"C Peters","year":"1998","unstructured":"Peters C, Shapiro EG, Anderson J et al. Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Blood 1998; 91: 2601\u20132608.","journal-title":"Blood"},{"key":"BF1704786_CR4","first-page":"250","volume":"2","author":"C Peters","year":"1998","unstructured":"Peters C, Shapiro EG, Krivit W . Neuropsychological development in children with Hurler syndrome following hematopoietic stem cell transplantation. Pediatr Transplant 1998; 2: 250\u2013253.","journal-title":"Pediatr Transplant"},{"key":"BF1704786_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/sj.bmt.1703395","volume":"29","author":"SS Grewal","year":"2002","unstructured":"Grewal SS, Krivit W, Defor TE et al. Outcome of second hematopoietic cell transplantation in Hurler syndrome. Bone Marrow Transplant 2002; 29: 491\u2013496.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704786_CR6","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1182\/blood-2002-06-1860","volume":"101","author":"GB McDonald","year":"2003","unstructured":"McDonald GB, Slattery JT, Bouvier ME et al. Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation. Blood 2003; 101: 2043\u20132048.","journal-title":"Blood"},{"key":"BF1704786_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1200\/JCO.1991.9.1.175","volume":"9","author":"HG Chun","year":"1991","unstructured":"Chun HG, Leyland-Jones B, Cheson BD . Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies. J Clin Oncol 1991; 9: 175\u2013188.","journal-title":"J Clin Oncol"},{"key":"BF1704786_CR8","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood.V92.4.1165","volume":"92","author":"MJ Keating","year":"1998","unstructured":"Keating MJ, O'Brien S, Lerner S et al. Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. Blood 1998; 92: 1165\u20131171.","journal-title":"Blood"},{"key":"BF1704786_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/sj.bmt.1704353","volume":"33","author":"Y Nieto","year":"2004","unstructured":"Nieto Y, Vaughan WP . Pharmacokinetics of high-dose chemotherapy. Bone Marrow Transplant 2004; 33: 259\u2013269.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704786_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0162-3109(94)90013-2","volume":"27","author":"J Schmidt","year":"1994","unstructured":"Schmidt J, Fleissner S, Heimann-Weitschat I et al. Effect of corticosteroids, cyclosporin A, and methotrexate on cytokine release from monocytes and T-cell subsets. Immunopharmacology 1994; 27: 173\u2013179.","journal-title":"Immunopharmacology"},{"key":"BF1704786_CR11","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/humu.1380060403","volume":"6","author":"HS Scott","year":"1995","unstructured":"Scott HS, Bunge S, Gal A et al. Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications. Hum Mutat 1995; 6: 288\u2013302.","journal-title":"Hum Mutat"},{"key":"BF1704786_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/humu.20081","volume":"24","author":"G Yogalingam","year":"2004","unstructured":"Yogalingam G, Guo XH, Muller VJ et al. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy. Hum Mutat 2004; 24: 199\u2013207.","journal-title":"Hum Mutat"},{"key":"BF1704786_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0022-3476(98)70201-X","volume":"133","author":"N Guffon","year":"1998","unstructured":"Guffon N, Souillet G, Maire I et al. Follow-up of nine patients with Hurler syndrome after bone marrow transplantation. J Pediatr 1998; 133: 119\u2013125.","journal-title":"J Pediatr"},{"key":"BF1704786_CR14","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1182\/blood.V82.3.1030.1030","volume":"82","author":"G Vassal","year":"1993","unstructured":"Vassal G, Fischer A, Challine D et al. Busulfan disposition below the age of three: alteration in children with lysosomal storage disease. Blood 1993; 82: 1030\u20131034.","journal-title":"Blood"},{"key":"BF1704786_CR15","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/sj.bmt.1703010","volume":"27","author":"P Jacobson","year":"2001","unstructured":"Jacobson P, Park JJ, Defor TE et al. Oral busulfan pharmacokinetics and engraftment in children with Hurler syndrome and other inherited metabolic storage diseases undergoing hematopoietic cell transplantation. Bone Marrow Transplant 2001; 27: 855\u2013861.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704786_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/00062752-199911000-00004","volume":"6","author":"W Krivit","year":"1999","unstructured":"Krivit W, Aubourg P, Shapiro E, Peters C . Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome. Curr Opin Hematol 1999; 6: 377\u2013382.","journal-title":"Curr Opin Hematol"},{"key":"BF1704786_CR17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1046\/j.1365-2141.2000.02305.x","volume":"111","author":"J Finke","year":"2000","unstructured":"Finke J, Bertz H, Schmoor C et al. Allogeneic bone marrow transplantation from unrelated donors using in vivo anti-T-cell globulin. Br J Haematol 2000; 111: 303\u2013313.","journal-title":"Br J Haematol"},{"key":"BF1704786_CR18","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/sj.bmt.1704209","volume":"32","author":"JH Dalle","year":"2003","unstructured":"Dalle JH, Wall D, Theoret Y et al. Intravenous busulfan for allogeneic hematopoietic stem cell transplantation in infants: clinical and pharmacokinetic results. Bone Marrow Transplant 2003; 32: 647\u2013651.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704786_CR19","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/sj.bmt.1704446","volume":"33","author":"L Nguyen","year":"2004","unstructured":"Nguyen L, Fuller D, Lennon S et al. I.V. busulfan in pediatrics: a novel dosing to improve safety\/efficacy for hematopoietic progenitor cell transplantation recipients. Bone Marrow Transplant 2004; 33: 979\u2013987.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704786_CR20","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1200\/JCO.1988.6.11.1768","volume":"6","author":"G Sarosy","year":"1988","unstructured":"Sarosy G, Leyland-Jones B, Soochan P, Cheson BD . The systemic administration of intravenous melphalan. J Clin Oncol 1988; 6: 1768\u20131782.","journal-title":"J Clin Oncol"},{"key":"BF1704786_CR21","first-page":"1049","volume":"18","author":"S Singhal","year":"1996","unstructured":"Singhal S, Powles R, Treleaven J et al. Melphalan alone prior to allogeneic bone marrow transplantation from HLA-identical sibling donors for hematologic malignancies: alloengraftment with potential preservation of fertility in women. Bone Marrow Transplant 1996; 18: 1049\u20131055.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704786_CR22","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/BF00255766","volume":"10","author":"IA Taha","year":"1983","unstructured":"Taha IA, Ahmad RA, Rogers DW et al. Pharmacokinetics of melphalan in children following high-dose intravenous injection. Cancer Chemother Pharmacol 1983; 10: 212\u2013216.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF1704786_CR23","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0140-6736(04)16628-2","volume":"364","author":"DA Jacobsohn","year":"2004","unstructured":"Jacobsohn DA, Duerst R, Tse W, Kletzel M . Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children. Lancet 2004; 364: 156\u2013162.","journal-title":"Lancet"},{"key":"BF1704786_CR24","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1056\/NEJMoa032613","volume":"350","author":"SL Staba","year":"2004","unstructured":"Staba SL, Escolar ML, Poe M et al. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med 2004; 350: 1960\u20131969.","journal-title":"N Engl J Med"},{"key":"BF1704786_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1053\/bbmt.2001.v7.pm11349809","volume":"7","author":"VT Ho","year":"2001","unstructured":"Ho VT, Weller E, Lee SJ et al. Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 223\u2013229.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1704786_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/sj.bmt.1703098","volume":"28","author":"DS Ritchie","year":"2001","unstructured":"Ritchie DS, Seymour JF, Roberts AW et al. Acute left ventricular failure following melphalan and fludarabine conditioning. Bone Marrow Transplant 2001; 28: 101\u2013103.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704786_CR27","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/S0952-7915(00)00135-7","volume":"12","author":"Y Reisner","year":"2000","unstructured":"Reisner Y, Martelli MF . Tolerance induction by \u2018megadose\u2019 transplants of CD34+ stem cells: a new option for leukemia patients without an HLA-matched donor. Curr Opin Immunol 2000; 12: 536\u2013541.","journal-title":"Curr Opin Immunol"},{"key":"BF1704786_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/sj.bmt.1704303","volume":"33","author":"P Lang","year":"2004","unstructured":"Lang P, Klingebiel T, Bader P et al. Transplantation of highly purified peripheral-blood CD34+ progenitor cells from related and unrelated donors in children with nonmalignant diseases. Bone Marrow Transplant 2004; 33: 25\u201332.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704786_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.bmt.1703314","volume":"29","author":"B Kremens","year":"2002","unstructured":"Kremens B, Basu O, Peceny R et al. Allogeneic CD34+-selected peripheral stem cell transplantation from parental donors in children with non-malignant diseases. Bone Marrow Transplant 2002; 29: 9\u201313.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704786_CR30","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1038\/sj.leu.2401581","volume":"13","author":"P Bader","year":"1999","unstructured":"Bader P, Klingebiel T, Schaudt A et al. Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children. Leukemia 1999; 13: 2079\u20132086.","journal-title":"Leukemia"},{"key":"BF1704786_CR31","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/sj.bmt.1704444","volume":"33","author":"P Bader","year":"2004","unstructured":"Bader P, Kreyenberg H, Hoelle W et al. Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective. Bone Marrow Transplant 2004; 33: 815\u2013821.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704786_CR32","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/sj.bmt.1704358","volume":"33","author":"P Woodard","year":"2004","unstructured":"Woodard P, Cunningham JM, Benaim E et al. Effective donor lymphohematopoietic reconstitution after haploidentical CD34+-selected hematopoietic stem cell transplantation in children with refractory severe aplastic anemia. Bone Marrow Transplant 2004; 33: 411\u2013418.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704786","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704786.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704786.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:38:07Z","timestamp":1648082287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,6]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,2,1]]}},"alternative-id":["BF1704786"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704786","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,6]]},"assertion":[{"value":"29 April 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}